180 related articles for article (PubMed ID: 3304626)
21. Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children.
Schindler E; Gullotta F
Virchows Arch A Pathol Anat Histopathol; 1983; 398(3):263-75. PubMed ID: 6298997
[TBL] [Abstract][Full Text] [Related]
22. Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer.
Bühren J; Christoph AH; Buslei R; Albrecht S; Wiestler OD; Pietsch T
J Neuropathol Exp Neurol; 2000 Mar; 59(3):229-40. PubMed ID: 10744061
[TBL] [Abstract][Full Text] [Related]
23. [A clinicopathological analysis of primitive neuroectodermal tumors of the CNS].
Zhang Q; Su X; Liang S
Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):282-5. PubMed ID: 11244998
[TBL] [Abstract][Full Text] [Related]
24. A clinicopathologic and immunohistochemical analysis of 53 cases of medulloblastoma with emphasis on synaptophysin expression.
Coffin CM; Braun JT; Wick MR; Dehner LP
Mod Pathol; 1990 Mar; 3(2):164-70. PubMed ID: 2109316
[TBL] [Abstract][Full Text] [Related]
25. Vimentin and glial fibrillary acidic protein in human brain tumors.
Yung WK; Luna M; Borit A
J Neurooncol; 1985; 3(1):35-8. PubMed ID: 3889231
[TBL] [Abstract][Full Text] [Related]
26. Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis.
Kalimo H; Paljärvi L; Ekfors T; Pelliniemi LJ
Pediatr Neurosci; 1987; 13(4):188-95. PubMed ID: 3136447
[TBL] [Abstract][Full Text] [Related]
27. Primitive neuroectodermal tumours of the cerebrum. Pathology and treatment.
Gaffney CC; Sloane JP; Bradley NJ; Bloom HJ
J Neurooncol; 1985; 3(1):23-33. PubMed ID: 2987425
[TBL] [Abstract][Full Text] [Related]
28. [Presence of glial fibrillary acidic protein as an indicator of cell differentiation in medulloblastoma].
Szymaś J; Biczysko W; Gabryel P
Neuropatol Pol; 1987; 25(3):313-27. PubMed ID: 2453814
[No Abstract] [Full Text] [Related]
29. Immunohistochemical evidence of neuronal and glial differentiation in retinoblastoma.
Xu KP; Liu SL; Ni C
Br J Ophthalmol; 1995 Aug; 79(8):771-6. PubMed ID: 7547791
[TBL] [Abstract][Full Text] [Related]
30. [Establishment and biological characterization of human medulloblastoma cell lines].
Yamada M; Shimizu K; Tamura K; Okamoto Y; Matsui Y; Moriuchi S; Park K; Mabuchi E; Yamamoto K; Hayakawa T
No To Shinkei; 1989 Jul; 41(7):695-702. PubMed ID: 2818910
[TBL] [Abstract][Full Text] [Related]
31. Dibutyryl cyclic AMP induces vimentin and GFAP expression in cultured medulloblastoma cells.
Maria BL; Wong D; Kalnins VI
Can J Neurol Sci; 1990 Feb; 17(1):15-20. PubMed ID: 2155693
[TBL] [Abstract][Full Text] [Related]
32. [Histological diagnosis of brain tumors: (19). Medulloblastoma].
Nagashima K
No Shinkei Geka; 1992 Jan; 20(1):9-13. PubMed ID: 1738431
[No Abstract] [Full Text] [Related]
33. [Glial fibrillary acidic protein and central nervous system tumors. Immunohistochemical study of a series of 207 cases. 2: Medulloblastomas. Hemangioblastomas. Other tumors. Discussion].
Pasquier B; Lachard A; Pasquier D; Couderc P; Delpech B; Courel MN
Ann Pathol; 1983 Sep; 3(3):203-11. PubMed ID: 6354202
[TBL] [Abstract][Full Text] [Related]
34. Differentiation in medulloblastomas: immunohistochemical study of twenty-one cases.
Aguilar D; Alvaro T; Camara M; Nogales F; O'Valle F; Del Moral RG; Gomez-Morales M; Aneiros J
Appl Pathol; 1989; 7(5):277-84. PubMed ID: 2517557
[TBL] [Abstract][Full Text] [Related]
35. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.
Katsetos CD; Herman MM; Frankfurter A; Gass P; Collins VP; Walker CC; Rosemberg S; Barnard RO; Rubinstein LJ
Arch Pathol Lab Med; 1989 Sep; 113(9):1019-29. PubMed ID: 2505732
[TBL] [Abstract][Full Text] [Related]
36. Medullocytoma (lipidized medulloblastoma). A cerebellar neoplasm of adults with favorable prognosis.
Giangaspero F; Cenacchi G; Roncaroli F; Rigobello L; Manetto V; Gambacorta M; Allegranza A
Am J Surg Pathol; 1996 Jun; 20(6):656-64. PubMed ID: 8651344
[TBL] [Abstract][Full Text] [Related]
37. Medulloblastomas in childhood: histological factors influencing patients' outcome.
Taomoto K; Tomita T; Raimondi AJ; Leestma JE
Childs Nerv Syst; 1987; 3(6):354-60. PubMed ID: 3450387
[TBL] [Abstract][Full Text] [Related]
38. Evidence for differentiation in medulloblastomas appearing primitive on light microscopy: an ultrastructural study.
Moss TH
Histopathology; 1983 Nov; 7(6):919-30. PubMed ID: 6662510
[TBL] [Abstract][Full Text] [Related]
39. Neuron-associated class III beta-tubulin, tau, and MAP2 in the D-283 Med cell line and in primary explants of human medulloblastoma.
Vinores SA; Herman MM; Katsetos CD; May EE; Frankfurter A
Histochem J; 1994 Aug; 26(8):678-85. PubMed ID: 7527016
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of various factors related to the prognosis of medulloblastoma].
Inoue I; Yoshida J; Kageyama N
No Shinkei Geka; 1985 Dec; 13(12):1283-9. PubMed ID: 4088450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
